Mitriou, C.S.; Hytiroglou, P. Progenitor cell activation in chronic viralhepatitis. Liver Int. 2004, 24, 26874. Lowes, K.N.; Brennan, B.A.; Yeoh, G.C.; Olynyk, J.K. Oval cell numbers in human chronic liver illnesses are straight connected to illness severity. Am. J. Pathol. 1999, 154, 53741. Knight, B.; Yeoh, G.C.; Husk, K.L.; Ly, T.; Abraham, L.J.; Yu, C.; Rhim, J.A.; Fausto, N. Impaired preneoplastic changes and liver tumor formation in tumor necrosis element receptor type 1 knockout mice. J. Exp. Med. 2000, 192, 1809818. Lowes, K.N.; Croager, E.J.; Olynyk, J.K.; Abraham, L.J.; Yeoh, G.C. Oval cell-mediated liver regeneration: Part of cytokines and growth factors. J. Gastroenterol. Hepatol. 2003, 18, 42. Knight, B.; Matthews, V.B.; Akhurst, B.; Croager, E.J.; Klinken, E.; Abraham, L.J.; Olynyk, J.K.; Yeoh, G. Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury. Immunol. Cell Biol. 2005, 83, 36474.four. 5. 6.7. eight.Int. J. Mol. Sci. 2014, 15 9. 10.11.12.13.14.15.16.17.18.19.20. 21. 22. 23.Brooling, J.T.; Campbell, J.S.; Mitchell, C.; Yeoh, G.C.; Fausto, N. Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma. Hepatology 2005, 41, 90615. Nguyen, L.N.; Furuya, M.H.; Wolfraim, L.A.; Nguyen, A.P.; Holdren, M.S.; Campbell, J.S.; Knight, B.; Yeoh, G.C.; Fausto, N.; Parks, W.T. Transforming development factor-beta differentially regulates oval cell and hepatocyte proliferation.SQ109 Hepatology 2007, 45, 311.Travoprost Hwang, G.PMID:23891445 Y.; Lin, C.Y.; Huang, L.M.; Wang, Y.H.; Wang, J.C.; Hsu, C.T.; Yang, S.S.; Wu, C.C. Detection in the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in situations of human hepatocellular carcinoma. J. Clin. Microbiol. 2003, 41, 5598603. Cheng, A.S.; Chan, H.L.; Leung, W.K.; To, K.F.; Go, M.Y.; Chan, J.Y.; Liew, C.T.; Sung, J.J. Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: Implication of HBx in upregulation of COX-2. Modern Pathol. 2004, 17, 1169179. Zhou, Y.M.; Cao, L.; Li, B.; Zhang, X.Z.; Yin, Z.F. Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma. Hepatobiliary Pancreat. Dis. Int. 2012, 11, 53235. Hsia, C.C.; Thorgeirsson, S.S.; Tabor, E. Expression of hepatitis B surface and core antigens and transforming growth factor-alpha in “oval cells” in the liver in sufferers with hepatocellular carcinoma. J. Med. Virol. 1994, 43, 21621. Watanabe, M.; Umenai, T.; Ohori, H.; Ishida, N. Evidence for the multiplication of hepatitis B virus in “oval cell” culture originated from human embryonic liver. Br. J. Exp. Pathol. 1976, 57, 21116. Chung, T.W.; Lee, Y.C.; Kim, C.H. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression via activation of ERK and PI-3K/AKT pathways: Involvement of invasive potential. FASEB J. 2004, 18, 1123125. Tang, R.X.; Kong, F.Y.; Fan, B.F.; Liu, X.M.; You, H.J.; Zhang, P.; Zheng, K.Y. HBx activates FasL and mediates HepG2 cell apoptosis via MLK3-MKK7-JNKs signal module. World J. Gastroenterol. 2012, 18, 1485495. Park, Y.H.; Shin, H.J.; Kim, S.U.; Kim, J.M.; Kim, J.H.; Bang, D.H.; Chang, K.T.; Kim, B.Y.; Yu, D.Y. iNOS promotes HBx-induced hepatocellular carcinoma through upregulation of JNK activation. Biochem. Biophys. Res. Commun. 2013, 435, 24449. Sze, K.M.; Chu, G.K.; Lee, J.M.; Ng, I.O. C-terminal truncated hepatitis B virus x protein is related to metastas.